Diminished ovarian reserve: is it a neglected cause in the assessment of recurrent miscarriage? A cohort study

被引:41
作者
Atasever, Melahat [1 ]
Soyman, Zeynep [2 ]
Demirel, Emine [3 ]
Gencdal, Servet [3 ]
Kelekci, Sefa [3 ]
机构
[1] Giresun Univ, Sch Med, Dept Obstet & Gynecol, Giresun, Turkey
[2] Istanbul Educ & Res Hosp, Dept Obstet & Gynecol, Minist Hlth, Istanbul, Turkey
[3] Izmir Katip Celebi Univ, Dept Obstet & Gynecol, Sch Med, Izmir, Turkey
关键词
Antimullerian hormone; antral follicle count; diminished ovarian reserve; ovarian reserve markers; recurrent miscarriage; FOLLICLE-STIMULATING-HORMONE; IN-VITRO FERTILIZATION; SERUM ANTIMULLERIAN-HORMONE; PREGNANCY LOSS; OOCYTE QUALITY; WOMEN; FSH; PERFORMANCE; POPULATION; PREDICTOR;
D O I
10.1016/j.fertnstert.2016.01.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To study whether diminished ovarian reserve is associated with recurrent miscarriage. Design: Cross-sectional clinical study. Setting: Tertiary-care center. Patient(s): Women with history of recurrent miscarriage (RM; n = 71) and sequentially selected age-matched fertile women who were seeking contraception (control; n = 70). Intervention(s): Not applicable. Main Outcome Measures(s): Serum levels of FSH, LH, E-2, and antimullerian hormone (AMH); FSH/LH ratio; ovarian volumes; and antral follicle count (AFC). Result(s): The levels of FSH were 8.6 +/- 3.7 U/L in the RM group and 7.1 +/- 3.9 U/L in the control group; this difference was statistically significant. The levels of AMH were significantly lower in the RM group than in the control group (2.9 +/- 1.7 ng/mL vs. 3.6 +/- 1.7 ng/mL). The percentage of women with levels of FSH >= 11 U/L was significantly higher in the RM group than in the control group (18.3% vs. 4.3%). In the RM group, the percentage of women with levels of AMH <= 1 ng/mL was significantly higher than in the control group (19.7% vs. 5.7%). Conclusion(s): Recurrent miscarriage may be associated with diminished ovarian reserve. Larger prospective randomized controlled trials are warranted to better determine the predictive potential of ovarian reserve markers in recurrent miscarriage. (C) 2016 by American Society for Reproductive Medicine.)
引用
收藏
页码:1236 / 1240
页数:5
相关论文
共 31 条
[1]  
[Anonymous], 2015, Obstet Gynecol, V125, P268, DOI 10.1097/01.AOG.0000459864.68372.ec
[2]  
[Anonymous], 2002, INT J GYNAECOL OBSTE, DOI DOI 10.1016/S0020-7292(02)00197-2
[3]   Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve [J].
Bancsi, LFJMM ;
Broekmans, FJM ;
Eijkemans, MJC ;
de Jong, FH ;
Habbema, JDF ;
te Velde, ER .
FERTILITY AND STERILITY, 2002, 77 (02) :328-336
[4]   Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles [J].
Ebner, T. ;
Sommergruber, M. ;
Moser, M. ;
Shebl, O. ;
Schreier-Lechner, E. ;
Tews, G. .
HUMAN REPRODUCTION, 2006, 21 (08) :2022-2026
[5]   Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome [J].
Freeman, SB ;
Yang, QH ;
Allran, K ;
Taft, LF ;
Sherman, SL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (05) :1680-1683
[6]   Serum antimullerian hormone is not predictive of oocyte quality in vitro fertilization [J].
Guerif, F. ;
Lemseffer, M. ;
Couet, M-L. ;
Gervereau, O. ;
Ract, V. ;
Royere, D. .
ANNALES D ENDOCRINOLOGIE, 2009, 70 (04) :230-234
[7]  
Gurbuz Birgul, 2004, Archives of Gynecology and Obstetrics, V270, P37
[8]   The predictive value of ovarian reserve tests for miscarriage in a population of subfertile ovulatory women [J].
Haadsma, M. L. ;
Groen, H. ;
Fidler, V. ;
Seinen, L. H. M. ;
Broekmans, F. J. M. ;
Heineman, M. J. ;
Hoek, A. .
HUMAN REPRODUCTION, 2009, 24 (03) :546-552
[9]   Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol [J].
Hazout, A ;
Bouchard, P ;
Seifer, DB ;
Aussage, P ;
Junca, AM ;
Cohen-Bacrie, P .
FERTILITY AND STERILITY, 2004, 82 (05) :1323-1329
[10]   Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population [J].
Hofmann, GE ;
Sosnowski, J ;
Scott, RT ;
Thie, J .
FERTILITY AND STERILITY, 1996, 66 (01) :49-53